A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of OnabotulinumtoxinA 200 U to Treat Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Faculty Opinions recommendation of A multicenter, randomized, double-blind, placebo controlled study of onabotulinumtoxinA 200 U to treat lower urinary tract symptoms in men with benign prostatic hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718270633.793512123 ◽

2015 ◽

Author(s):

Peter Gilling

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial

Arab Journal of Urology ◽

10.1016/j.aju.2016.11.001 ◽

2017 ◽

Vol 15 (1) ◽

pp. 53-59 ◽

Cited By ~ 10

Author(s):

Amr Fawzi ◽

Mostafa Kamel ◽

Emad Salem ◽

Esam Desoky ◽

Mohamed Omran ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Double-blind randomized placebo-controlled study of bixa orellana in patients with lower urinary tract symptoms associated to benign prostatic hyperplasia

International braz j urol ◽

10.1590/s1677-55382007000400006 ◽

2007 ◽

Vol 33 (4) ◽

pp. 493-501 ◽

Cited By ~ 11

Author(s):

Luis Zegarra ◽

Abraham Vaisberg ◽

Cesar Loza ◽

Roxana L. Aguirre ◽

Miguel Campos ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Bixa Orellana ◽

Double Blind ◽

Urinary Tract Symptoms ◽

Daily use of sildenafil 50mg at night effectively ameliorates nocturia in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: an exploratory multicenter, double-blind, randomized, placebo-controlled study

The Aging Male ◽

10.1080/13685538.2016.1204290 ◽

2017 ◽

Vol 20 (2) ◽

pp. 81-88 ◽

Cited By ~ 9

Author(s):

Woo Jin Ko ◽

Hyun Ho Han ◽

Won Sik Ham ◽

Hae Won Lee

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Double Blind ◽

Urinary Tract Symptoms ◽

641 Monotherapy with tadalafil or tamsulosin for moderate-to-severe lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): Results from an international, double-blind, placebo-controlled trial

European Urology Supplements ◽

10.1016/s1569-9056(12)60638-1 ◽

2012 ◽

Vol 11 (1) ◽

pp. e641-e641a

Author(s):

M. Oelke ◽

F. Giuliano ◽

V. Mirone ◽

L. Xu ◽

D. Cox ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Sexual Function in Men with Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia: Results of a 6‐Month, Randomized, Double‐Blind, Placebo‐Controlled Study of Tadalafil Coadministered with Finasteride

Journal of Sexual Medicine ◽

10.1111/jsm.12714 ◽

2015 ◽

Vol 12 (1) ◽

pp. 129-138 ◽

Cited By ~ 26

Author(s):

Sidney Glina ◽

Claus G. Roehrborn ◽

Adil Esen ◽

Alexey Plekhanov ◽

Sebastian Sorsaburu ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Prostatic Enlargement ◽

Reply to Stephen Shei-Dei Yang and Shang-Jen Chang's Letter to the Editor re: Christopher R. Chapple, Francesco Montorsi, Teuvo L.J. Tammela, et al. Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe. Eur Urol 2011;59:342–52

European Urology ◽

10.1016/j.eururo.2011.04.037 ◽

2011 ◽

Vol 60 (2) ◽

pp. e12-e13

Author(s):

Christopher R. Chapple

Keyword(s):

Clinical Trial ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

543 Efficacy and safety of desmopressin “add-on” therapy in men with persistent nocturia under alpha blocker monotherapy for lower urinary tract symptoms: A randomized, double-blind, placebo-controlled study

European Urology Supplements ◽

10.1016/s1569-9056(16)60545-6 ◽

2016 ◽

Vol 15 (3) ◽

pp. e543 ◽

Cited By ~ 2

Author(s):

K.J. Cho ◽

Z.Z. Lee ◽

J.G. Lee ◽

J.T. Seo ◽

D.Y. Kim ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Alpha Blocker ◽

Urinary Tract Symptoms ◽

Faculty Opinions recommendation of A randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs. tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717952981.793458533 ◽

2012 ◽

Author(s):

Geoffrey Hackett

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Safety And Efficacy ◽

Urinary Tract Symptoms ◽

Faculty Opinions recommendation of Erectile and ejaculatory function preserved with convective water vapor energy treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: randomized controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726323134.793564003 ◽

2019 ◽

Author(s):

Alexis Te

Keyword(s):

Water Vapor ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Randomized Controlled ◽

Urinary Tract Symptoms ◽